Uses
Oraqix is an amide local anesthetic indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing.
Source: US FDA prescribing information
Fixed-dose combination
Lidocaine and Prilocaine
Also known as lidocaine, prilocaine
Available on requestPain and anaesthesia
- Presentations
- 2
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Lidocaine and Prilocaine is a fixed-dose combination of an amide local anesthetic and an antiarrhythmic indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing. MedsAcross supplies Lidocaine and Prilocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Amide Local Anesthetic, Antiarrhythmic, Local Anesthesia
- ATC classification
- N01BB20 Lidocaine and Prilocaine · Local anesthetic, subgroup N01BB
- US FDA first approval
- 30 December 1992
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Topical, Periodontal
- Dosage forms
- Cream, Gel
- Fixed-dose combination of
- Lidocaine, Prilocaine
- Identifiers
- RxCUI 166283CAS 101362-25-8Q4019783
Clinical information
From the regulator-approved product information. Each section names its source.
How it works
Lidocaine and prilocaine belong to the amide class of local anesthetics. Both lidocaine and prilocaine block sodium ion channels required for the initiation and conduction of neuronal impulses, resulting in local anesthesia.
Source: US FDA prescribing information
Dosing overview
Use the included blunt-tipped applicator and the dispenser, which is sold separately, to apply gel to gingival margins and periodontal pockets. May be reapplied as needed up to a maximum of 5 cartridges per treatment session.
Source: US FDA prescribing information
Contraindications
Oraqix is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any other component of the product. A history of hypersensitivity to local anesthetics of the amide type. A history of hypersensitivity to any component of the product
Source: US FDA prescribing information
Warnings and precautions
Methemoglobinemia: Cases of methemoglobinemia have been reported in association with local anesthetic use. DO NOT INJECT. Allergic and anaphylactic reactions can occur. Avoid contact with eyes. Use with caution in patients with severe hepatic disease
Source: US FDA prescribing information
Side effects
Most common adverse reactions (incidence >15%) are application site reactions including pain, soreness, irritation, numbness, ulcerations, vesicles, edema, abscess and/or redness.
Source: US FDA prescribing information
Interactions
Other local anesthetics or agents structurally related to local anesthetics. Drugs That May Cause Methemoglobinemia When Used With ORAQIX
Source: US FDA prescribing information
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F). At temperatures below +5°C Oraqix may become opaque. This opacity will disappear when the cartridge is warmed to room temperature. DO NOT FREEZE.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
2 presentations of Lidocaine and Prilocaine, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Lidocaine and Prilocaine 25 mg/25 mg per g creamTopicalGeneric name | Lidocaine and Prilocaine | — | US FDA | Available on request |
| Oraqix 25 mg/25 mg per g gelPeriodontal | Lidocaine and Prilocaine | Dentsply Pharmaceutical | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Lidocaine and Prilocaine available for export from India?
Yes, on request. MedsAcross lists 2 presentations of Lidocaine and Prilocaine and sources them for licensed hospitals, importers and physicians against valid import documents.
What brand names does Lidocaine and Prilocaine have?
The catalogue lists 1 brand names for Lidocaine and Prilocaine, including Oraqix.
Is Lidocaine and Prilocaine approved by the US FDA?
Yes. The US FDA first approved Lidocaine and Prilocaine on 30 December 1992, according to Drugs@FDA.
Is Lidocaine and Prilocaine authorised in the European Union?
Yes. Lidocaine and Prilocaine has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Lidocaine and Prilocaine need cold chain shipping?
No listed presentation of Lidocaine and Prilocaine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Lidocaine and Prilocaine in?
Lidocaine and Prilocaine is classified under ATC code N01BB20 (Lidocaine and Prilocaine).
References
- Oraqix prescribing information (Dentsply Pharmaceutical). U.S. National Library of Medicine, DailyMed. Retrieved 21 April 2026
- Fortacin: European public assessment report (EPAR). European Medicines Agency. Retrieved 3 February 2025
Request Lidocaine and Prilocaine for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.